CRO Services
CRO Services
Top 5 Ways Integrated Drug Development Solutions Save You Time and Money
Since 2004, the average cost of bringing a new drug to market has increased from $800 million to about $2.6 billion, without, for the most part, shorter development time
Bioanalysis—Three Decades in the Making
Improving Your Quality Toolbox with Quality Metrics
ISSUE NO. 29 — Building Your Early Phase Clinical Data, from Protocol to Regulatory Submission
ISSUE NO. 26 — CDISC Data Standards
The Clinical Data I
ISSUE NO. 23 — Robust Sample Management for Reliable Study Results
Q&A: Setting Up Your Clinical Research for Success, With Dr. Nicole Maciolek
.custom-column-left-text {
float: left;
width: 45%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}
Tying together the phases of your drug development program are the essential research support services that help your drug candidates not only meet their milestones, but also regulator
One Integrated Solution for Meeting Your Preclinical to Clinical Drug Development Needs
Five Things You Need to Know About Partnering with an Integrated CRO/CDMO
.custom-column-left-text {
float: left;
width: 50%;
padding-right: 10px;
}
.custom-column-right-text {
float: right;
width: 45%;
text-align:center;
}
@media only screen and (max-width: 600px) {
.custom-column-left-text,
.custom-column-right-text,
.custom-column-flc-ebook-text {
float:none;
width:80%;
margin:0 auto;
}
}
We are often asked about the advantages of working with an integrated CRO/CDMO.